Cargando…
The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer
BACKGROUND: To describe the characteristics of plasma lipid proliferation in cervical cancer and further evaluate the prognostic significance of lipid levels in cervical cancer. METHODS: We retrospectively reviewed 1713 patients with cervical cancer in our hospital. The preoperative plasma lipid pro...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012499/ https://www.ncbi.nlm.nih.gov/pubmed/35431573 http://dx.doi.org/10.2147/IJGM.S352934 |
_version_ | 1784687807585845248 |
---|---|
author | Jiang, Qi Wang, Luhui Jin, Mengya Shou, Yueyao Zhu, Haiyan Li, Anyang |
author_facet | Jiang, Qi Wang, Luhui Jin, Mengya Shou, Yueyao Zhu, Haiyan Li, Anyang |
author_sort | Jiang, Qi |
collection | PubMed |
description | BACKGROUND: To describe the characteristics of plasma lipid proliferation in cervical cancer and further evaluate the prognostic significance of lipid levels in cervical cancer. METHODS: We retrospectively reviewed 1713 patients with cervical cancer in our hospital. The preoperative plasma lipid profile, including cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL), of 1713 cervical cancer patients was compared with that of 10,397 healthy women. Then, we evaluated the impact of lipids on overall survival (OS) and recurrence-free survival (RFS) in cervical cancer using univariate and multivariate Cox models. RESULTS: While plasma TC, TG, and LDL were significantly higher, HDL was lower in patients with cervical cancer than in healthy women. TG was identified as an independent predictor for RFS and OS among patients with cervical cancer. Further stratified by age, patients with higher TGs showed a significantly worse RFS and OS than those with lower TGs among patients ≥50 years old but not among those <50 years old. CONCLUSION: Cervical cancer was associated with a disordered lipid profile. Hypertriglyceridemia was an independent poor prognostic indicator for cervical cancer, especially for elderly patients. Strengthening lipid management may be beneficial for improving postoperative OS and RFS in patients with cervical cancer. |
format | Online Article Text |
id | pubmed-9012499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-90124992022-04-16 The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer Jiang, Qi Wang, Luhui Jin, Mengya Shou, Yueyao Zhu, Haiyan Li, Anyang Int J Gen Med Original Research BACKGROUND: To describe the characteristics of plasma lipid proliferation in cervical cancer and further evaluate the prognostic significance of lipid levels in cervical cancer. METHODS: We retrospectively reviewed 1713 patients with cervical cancer in our hospital. The preoperative plasma lipid profile, including cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL), and low-density lipoprotein cholesterol (LDL), of 1713 cervical cancer patients was compared with that of 10,397 healthy women. Then, we evaluated the impact of lipids on overall survival (OS) and recurrence-free survival (RFS) in cervical cancer using univariate and multivariate Cox models. RESULTS: While plasma TC, TG, and LDL were significantly higher, HDL was lower in patients with cervical cancer than in healthy women. TG was identified as an independent predictor for RFS and OS among patients with cervical cancer. Further stratified by age, patients with higher TGs showed a significantly worse RFS and OS than those with lower TGs among patients ≥50 years old but not among those <50 years old. CONCLUSION: Cervical cancer was associated with a disordered lipid profile. Hypertriglyceridemia was an independent poor prognostic indicator for cervical cancer, especially for elderly patients. Strengthening lipid management may be beneficial for improving postoperative OS and RFS in patients with cervical cancer. Dove 2022-04-11 /pmc/articles/PMC9012499/ /pubmed/35431573 http://dx.doi.org/10.2147/IJGM.S352934 Text en © 2022 Jiang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Jiang, Qi Wang, Luhui Jin, Mengya Shou, Yueyao Zhu, Haiyan Li, Anyang The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer |
title | The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer |
title_full | The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer |
title_fullStr | The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer |
title_full_unstemmed | The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer |
title_short | The Clinical Value of Lipid Abnormalities in Early Stage Cervical Cancer |
title_sort | clinical value of lipid abnormalities in early stage cervical cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012499/ https://www.ncbi.nlm.nih.gov/pubmed/35431573 http://dx.doi.org/10.2147/IJGM.S352934 |
work_keys_str_mv | AT jiangqi theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT wangluhui theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT jinmengya theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT shouyueyao theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT zhuhaiyan theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT lianyang theclinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT jiangqi clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT wangluhui clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT jinmengya clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT shouyueyao clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT zhuhaiyan clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer AT lianyang clinicalvalueoflipidabnormalitiesinearlystagecervicalcancer |